Incorporation of Biologic Therapies in the Management of Gastroesophageal Cancers

Por Jhawer, Minaxi, Kelsen, David, Shah, Manish
Publicado em 2007

Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil With Bevacizumab in Patients With Metastatic Gastroesophageal Adenocarcinoma

Por Shah, Manish A., Jhawer, Minaxi, Ilson, David H., Lefkowitz, Robert A., Robinson, Edric, Capanu, Marinela, Kelsen, David P.
Publicado em 2011

PIK3CA mutation / PTEN expression status predicts response of colon cancer cells to the EGFR inhibitor cetuximab

Por Jhawer, Minaxi, Goel, Sanjay, Wilson, Andrew J., Montagna, Cristina, Ling, Yi-He, Byun, Do-Sun, Nasser, Shannon, Arango, Diego, Shin, Joongho, Klampfer, Lidija, Augenlicht, Leonard H., Soler, Roman Perez, Mariadason, John M.
Publicado em 2008

An A13 repeat within the 3’UTR of EGFR is frequently mutated in MSI colon cancers and is associated with increased EGFR expression

Por Yuan, Ziqiang, Shin, Joongho, Wilson, Andrew, Goel, Sanjay, Ling, Yi-He, Ahmed, Naseem, Dopeso, Higinio, Jhawer, Minaxi, Nasser, Shannon, Montagna, Cristina, Fordyce, Kenneth, Augenlicht, Leonard H., Aaltonen, Lauri A., Arango, Diego, Weber, Thomas K., Mariadason, John M.
Publicado em 2009

A coordinated Sp1/Sp3-mediated transcriptional response involving immediate-early gene induction is linked to HDAC inhibitor-induced apoptosis in colon cancer cells

Por Wilson, Andrew J., Chueh, Anderly C., Tögel, Lars, Corner, Georgia A., Ahmed, Naseem, Goel, Sanjay, Byun, Do-Sun, Nasser, Shannon, Houston, Michele A., Jhawer, Minaxi, Smartt, Helena J.M., Murray, Lucas B., Nicholas, Courtney, Heerdt, Barbara G., Arango, Diego, Augenlicht, Leonard H., Mariadason, John M.
Publicado em 2010